Literature DB >> 28547522

Understanding hepatic encephalopathy.

Nicolas Weiss1,2,3, Rajiv Jalan4, Dominique Thabut5,6,7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28547522     DOI： 10.1007/s00134-017-4845-6

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  15 in total

1.  Severity of the compensatory anti-inflammatory response determined by monocyte HLA-DR expression may assist outcome prediction in cirrhosis.

Authors:  Philip A Berry; Charalambos G Antoniades; Ivana Carey; Mark J W McPhail; Munther J Hussain; Edward T Davies; Julia A Wendon; Diego Vergani
Journal:  Intensive Care Med       Date:  2010-12-16       Impact factor: 17.440

2.  Modification in CSF specific gravity in acutely decompensated cirrhosis and acute on chronic liver failure independent of encephalopathy, evidences for an early blood-CSF barrier dysfunction in cirrhosis.

Authors:  Nicolas Weiss; Matteo Rosselli; Sarah Mouri; Damien Galanaud; Louis Puybasset; Banwari Agarwal; Dominique Thabut; Rajiv Jalan
Journal:  Metab Brain Dis       Date:  2016-10-11       Impact factor: 3.584

3.  Patients with acute on chronic liver failure display "sepsis-like" immune paralysis.

Authors:  Hermann E Wasmuth; Dagmar Kunz; Eray Yagmur; Annette Timmer-Stranghöner; Daniel Vidacek; Elmar Siewert; Jens Bach; Andreas Geier; Edmund A Purucker; Axel M Gressner; Siegfried Matern; Frank Lammert
Journal:  J Hepatol       Date:  2005-02       Impact factor: 25.083

4.  FOUR score, a reliable score for assessing overt hepatic encephalopathy in cirrhotic patients.

Authors:  Sarah Mouri; Simona Tripon; Marika Rudler; Maxime Mallet; Julien Mayaux; Dominique Thabut; Nicolas Weiss
Journal:  Neurocrit Care       Date:  2015-04       Impact factor: 3.210

5.  Variations in the promoter region of the glutaminase gene and the development of hepatic encephalopathy in patients with cirrhosis: a cohort study.

Authors:  Manuel Romero-Gómez; María Jover; José A Del Campo; José L Royo; Elena Hoyas; José J Galán; Carmina Montoliu; Eugenia Baccaro; Mónica Guevara; Juan Córdoba; Germán Soriano; José M Navarro; Carmen Martínez-Sierra; Lourdes Grande; Antonio Galindo; Emilia Mira; Santos Mañes; Agustín Ruiz
Journal:  Ann Intern Med       Date:  2010-09-07       Impact factor: 25.391

6.  Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998.

Authors:  Peter Ferenci; Alan Lockwood; Kevin Mullen; Ralph Tarter; Karin Weissenborn; Andres T Blei
Journal:  Hepatology       Date:  2002-03       Impact factor: 17.425

7.  Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis.

Authors:  Debbie L Shawcross; Nathan A Davies; Roger Williams; Rajiv Jalan
Journal:  J Hepatol       Date:  2004-02       Impact factor: 25.083

8.  Model for end-stage liver disease score and systemic inflammatory response are major prognostic factors in patients with cirrhosis and acute functional renal failure.

Authors:  Dominique Thabut; Julien Massard; Alice Gangloff; Nicolas Carbonell; Claire Francoz; Eric Nguyen-Khac; Christian Duhamel; Didier Lebrec; Thierry Poynard; Richard Moreau
Journal:  Hepatology       Date:  2007-12       Impact factor: 17.425

Review 9.  Neurotransmitter receptor alterations in hepatic encephalopathy: a review.

Authors:  Nicola Palomero-Gallagher; Karl Zilles
Journal:  Arch Biochem Biophys       Date:  2013-03-01       Impact factor: 4.013

Review 10.  Ammonia and amino acid profiles in liver cirrhosis: effects of variables leading to hepatic encephalopathy.

Authors:  Milan Holecek
Journal:  Nutrition       Date:  2014-03-30       Impact factor: 4.008
View more
  9 in total

Review 1.  Multimodal MR imaging in hepatic encephalopathy: state of the art.

Authors:  Xiao Dong Zhang; Long Jiang Zhang
Journal:  Metab Brain Dis       Date:  2018-01-26       Impact factor: 3.584

2.  The ten tips to manage critically ill patients with acute-on-chronic liver failure.

Authors:  Valentin Fuhrmann; Tony Whitehouse; Julia Wendon
Journal:  Intensive Care Med       Date:  2018-01-31       Impact factor: 17.440

3.  Ammonia rises from the ashes!

Authors:  Nicolas Weiss; Dominique Thabut
Journal:  JHEP Rep       Date:  2022-08-18

4.  Novel D-galactosamine-induced cynomolgus monkey model of acute liver failure.

Authors:  Lei Feng; Lei Cai; Guo-Lin He; Jun Weng; Yang Li; Ming-Xin Pan; Ze-Sheng Jiang; Qing Peng; Yi Gao
Journal:  World J Gastroenterol       Date:  2017-11-14       Impact factor: 5.742

5.  MetaboRank: network-based recommendation system to interpret and enrich metabolomics results.

Authors:  Clément Frainay; Sandrine Aros; Maxime Chazalviel; Thomas Garcia; Florence Vinson; Nicolas Weiss; Benoit Colsch; Frédéric Sedel; Dominique Thabut; Christophe Junot; Fabien Jourdan
Journal:  Bioinformatics       Date:  2019-01-15       Impact factor: 6.937

Review 6.  Cognitive Function in Liver Transplantation.

Authors:  Somaya A M Albhaisi; Jasmohan S Bajaj
Journal:  Curr Transplant Rep       Date:  2020-03-26

7.  Probiotics improve the neurometabolic profile of rats with chronic cholestatic liver disease.

Authors:  Veronika Rackayová; Emmanuelle Flatt; Olivier Braissant; Jocelyn Grosse; Daniela Capobianco; Paola Mastromarino; Matthew McMillin; Sharon DeMorrow; Valérie A McLin; Cristina Cudalbu
Journal:  Sci Rep       Date:  2021-01-26       Impact factor: 4.379

8.  Development and Validation of a Prognostic Model for One-year Survival of Cirrhosis Patients with First-ever Spontaneous Bacterial Peritonitis.

Authors:  Rui-Rui Wang; Hong-Qiu Gu; Ying-Ying Wei; Jin-Xiang Yang; Yi-Xin Hou; Hui-Min Liu; Zhi-Yun Yang; Xian-Bo Wang; Yu-Yong Jiang
Journal:  J Clin Transl Hepatol       Date:  2021-05-24

9.  Serum ammonia is a strong prognostic factor for patients with acute-on-chronic liver failure.

Authors:  Chenxia Hu; Kaizhou Huang; Lingfei Zhao; Fen Zhang; Zhongwen Wu; Lanjuan Li
Journal:  Sci Rep       Date:  2020-10-12       Impact factor: 4.379
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.